Skip to Main Content

+

  • • Account for 1.5% of GI tract cancers

    • Usually long history of perianal complaints

    • Disease may be quite extensive at presentation

    • Associated with chronic anal infection (human papillomavirus)

    • Tumors anatomically found from the upper to lower border of the internal anal sphincter, 6-12 mm above dentate line

    • Referred to as epidermoid carcinoma

++

Epidemiology

+

  • • Women are at increased risk

    • Homosexual males at greatly increased risk

    • 7/106 men; 9/106 women

    • Increased incidence in males and females practicing anal sex

    • Increased risk with history of anogenital warts; STD; > 10 sexual partners; cervical, vulvar, or vaginal cancer

    • Increased incidence in persons who smoke or who are immunosuppressed (HIV infection and transplantation)

++

Symptoms and Signs

+

  • • Perianal irritation, may be long-standing

    • Palpable mass, may be indurated

    • Bleeding

    • Itching

    • Tenesmus

++

Laboratory Findings

+

  • • No specific abnormalities

++

Imaging Findings

+

  • CT/MRI: Reveal anal mass

    Endorectal US: Reveals size and depth of invasion and perianal nodes

+

  • • Tumor of anal margin

    • Hemorrhoids

    • Anal melanoma

    • Perianal/perirectal abscess/fistula

    • Low rectal cancer

++

Rule Out

+

  • • Extension of low rectal adenocarcinoma

    • Anal melanoma

+

  • • Physical exam with digital rectal exam

    • Assessment for lymphadenopathy (groins)

    • Exam under anesthesia, anoscopy with biopsy

    • Endorectal US to assess size and depth of invasion

    • Chest film, CT to assess for metastatic disease

++

When to Admit

+

  • • Severe bleeding with hemodynamic compromise

    • Intractable symptoms: itching, pain

+

  • • Chemoradiation is mainstay of therapy

    • Role of surgery limited

    • Overall reported recurrence rates with local excision high

++

Surgery

++

Indications

+

  • • Local excision for small, well-differentiated, mobile lesions confined to the submucosa

    • Surgery is largely used as salvage procedure or for recurrent/persistent disease (abdominal perineal resection)

++

Contraindications

+

  • • Nigro protocol of chemoradiation is first-line therapy

++

Medications

+

  • • Radiation therapy (XRT): 30 Gray to primary tumor and pelvic and inguinal nodes

    • Mitomycin is given on day 1 of XRT

    • Two 4-day infusions of 5-fluorouracil (5-FU) given on day 1 and day 28 of chemoradiation therapy

    • Cisplatin may be used in place of mitomycin

++

Treatment Monitoring

+

  • • Follow-up rectal and node exam

++

Complications

+

  • • Recurrence of disease

    • Metastatic disease

++

Prognosis

+

  • • Tumor size is best predictor

    • Mobile lesions < 2 cm have cure rates of 80%

    • Tumors > 5 cm associated with 50% mortality

    • Metastatic disease more likely to be present with increasing depth of invasion, size, and histologic grade

    • Lymph node disease at presentation is poor prognostic indicator

    • 40% ...

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.